IBI-322

CAT: 0931-T9901A-1578-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0931-T9901A-1578-01Size:1 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Target
PD-1/PD-L1|||Others
Related Pathways
Apoptosis|||Others|||Immunology/Inflammation|||Cell Cycle/Checkpoint
Bioactivity
IBI-322 is a bispecific antibody targeting PD-L1 and CD47. In monovalent binding, it can attenuate the activity of CD47, and in bivalent binding, it can block the activity of PD-L1. IBI-322 selectively binds to CD47+PD-L1+ tumor cells, effectively inhibiting the CD47-SIRP? signaling and inducing strong tumor cell phagocytosis in vitro.
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Popular Products